Sanofi filed its 13F report for Q4 2025 on February 11, 2026. The portfolio totaled 310.41 M reflecting a +19.22% change from the prior quarter, spanning 8 assets. The top 10 holdings comprised 100.0% of the portfolio, with Financials as the largest sector allocation. Quarterly activity included 1 new positions and 2 complete exits.
Items:
Total Value:
| Issuer Name | Class | Value | Shares | Option Type |
|---|
Sanofi submitted their Form 13F-HR for the Q4 2025 period on 02/11/2026. This was the only submission for the quarter.
In the Q4 2025 filing, Sanofi reported a managed portfolio value of 310.41 M, consisting of 8 individual positions.
This page displays the raw filing documents. To see which stocks Sanofi bought or sold during Q4 2025, please visit Sanofi's Portfolio Analysis page.